Protein expression of hypoxia-inducible factor-1 alpha and hepatocellular carcinoma: A systematic review with meta-analysis

Clinics and Research in Hepatology and Gastroenterology

Volumn 38, Issue 5, 2014, Pages 598-603

  Cao, Shiyi ^a   Yang, Shengli ^a   Wu, Chao ^a   Wang, Yunxia ^a   Jiang, Jianxin ^b   Lu, Zuxun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; DISEASE FREE SURVIVAL; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PROTEIN EXPRESSION; SYSTEMATIC REVIEW; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR VOLUME; BIOSYNTHESIS; LIVER TUMOR; META ANALYSIS; METABOLISM;

CARCINOMA, HEPATOCELLULAR; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER NEOPLASMS;

EID: 84912525627     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2014.04.004     Document Type: Article

References (23)

1. Ferlay J., et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127(12):2893-2917.
2. Blechacz B., et al. Hepatocellular carcinoma biology. Recent Results Cancer Res 2013, 190:1-20.
3. Semenza G.L. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 2012, 33(4):207-214.
4. Yang Y., et al. HIFs, angiogenesis, and cancer. J Cell Biochem 2013, 114(5):967-974.
5. Majmundar A.J., et al. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 2010, 40(2):294-309.
6. Chen Y., et al. Overexpression of semaphorin4D, hypoxia-inducible factor-1alpha and vascular endothelial growth factor is related to poor prognosis in ovarian epithelial cancer. Int J Mol Sci 2012, 13(10):13264-13274.
7. Kaya A.O., et al. Hypoxia-inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients. J BUON 2012, 17(4):663-668.
8. Erpolat O.P., et al. Hypoxia-related molecules HIF-1alpha, CA9, and osteopontin: predictors of survival in patients with high-grade glioma. Strahlenther Onkol 2013, 189(2):147-154.
9. Volm M., et al. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res 2000, 20(3A):1527-1533.
10. Lidgren A., et al. The expression of hypoxia-inducible factor 1alpha is a favorable independent prognostic factor in renal cell carcinoma. Clin Cancer Res 2005, 11(3):1129-1135.
11. Huang G.W., et al. Expression of hypoxia-inducible factor 1 a and vascular endothelial growth factor in hepatocellular carcinoma: impact on neovascularization and survival. World J Gastroenterol 2005, 11(11):1705-1708.
12. Wada H., et al. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1a. Liver Int 2006, 26(4):414-423.
13. Yu D., et al. Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma. BMC Cancer 2007, 7(1):122.
14. Xie H., et al. The expression of hypoxia-inducible factor-1α in hepatitis B virus-related hepatocellular carcinoma: correlation with patients' prognosis and hepatitis B virus X protein. Dig Dis Sci 2008, 53(12):3225-3233.
15. Dai C.X., et al. Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery. BMC Cancer 2009, 9(1):418.
16. Simon F., et al. Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue-influence of a modulated host stroma on the prognosis of HCC. Langenbeck's Arch Surg 2010, 395(4):395-405.
17. Li S., et al. Expression characteristics of hypoxia-inducible factor-1α and its clinical values in diagnosis and prognosis of hepatocellular carcinoma. Hepat Mon 2011, 11(10):821.
18. Xiang Z.L., et al. Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma. Clin Cancer Res 2011, 17(16):5463-5472.
19. Xiang Z.L., et al. The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome. Mol Biol Rep 2012, 39(2):2021-2029.
20. Stroup D.F., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283(15):2008-2012.
21. Higgins J.P., et al. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560.
22. DerSimonian R., et al. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188.
23. Nath B., et al. Hypoxia and hypoxia-inducible factors: diverse roles in liver diseases. Hepatology 2012, 55(2):622-633.